Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Mar 17, 2026, 4:32 pm EDT Sports Business © 2026 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site ...
Ranked by Enplaned passengers at RDU from Jan. 1, 2025, through Dec. 31, 2025 Showcase your company news with guaranteed exposure both in print and online For 28 years Triangle Business Journal has ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results